| PBHPrestige Consumer Healthcare Inc. |
1,1 mld USD |
17,5% |
2026 |
| PRHIPresurance Holdings, Inc. |
43,3 mln USD |
-42,6% |
2025 |
| PRIAFPrime Impact Acquisition I |
b.d. |
b.d. |
2022 |
| PRMEPrime Medicine, Inc. |
4,6 mln USD |
-4342,4% |
2025 |
| PMECPrimech Holdings Ltd |
74,3 mln USD |
-2,6% |
2025 |
| PRIPrimerica, Inc. |
3,3 mld USD |
22,7% |
2025 |
| FRSTPrimis Financial Corp. |
b.d. |
b.d. |
2025 |
| PRMBPrimo Brands Corp |
6,7 mld USD |
0,9% |
2025 |
| PRIMPrimoris Services Corp |
7,6 mld USD |
3,6% |
2025 |
| BPRNPrinceton Bancorp, Inc. |
b.d. |
b.d. |
2025 |
| PDSKXPrincipal Real Asset Fund |
b.d. |
b.d. |
b.d. |
| PGZPrincipal Real Estate Income Fund |
b.d. |
b.d. |
b.d. |
| PRIF-PDPriority Income Fund, Inc. |
b.d. |
b.d. |
b.d. |
| PRTHPriority Technology Holdings, Inc. |
953 mln USD |
5,8% |
2025 |
| PBAMPrivate Bancorp of America, Inc. |
b.d. |
b.d. |
b.d. |
| PRVAPrivia Health Group, Inc. |
2,1 mld USD |
1,1% |
2025 |
| PCAPProCap Acquisition Corp |
b.d. |
b.d. |
2025 |
| BRRProCap Financial, Inc. |
b.d. |
b.d. |
b.d. |
| ACDCProFrac Holding Corp. |
1,9 mld USD |
-19,0% |
2025 |
| PMNProMIS Neurosciences Inc. |
b.d. |
b.d. |
2025 |
| PUMPProPetro Holding Corp. |
1,3 mld USD |
0,1% |
2025 |
| PRPHProPhase Labs, Inc. |
4,3 mln USD |
-339,3% |
2025 |
| PRQRProQR Therapeutics N.V. |
15,9 mln € |
-265,2% |
2025 |
| AGQProShares Trust II |
b.d. |
b.d. |
2025 |
| PCSAProcessa Pharmaceuticals, Inc. |
b.d. |
b.d. |
2025 |
| PAACProem Acquisition Corp. I |
b.d. |
b.d. |
b.d. |
| IPDNProfessional Diversity Network, Inc. |
6,5 mln USD |
-98,5% |
2025 |
| PALProficient Auto Logistics, Inc |
b.d. |
b.d. |
2025 |
| PROFProfound Medical Corp. |
16,1 mln USD |
-264,4% |
2025 |
| PFSAProfusa, Inc. |
b.d. |
b.d. |
2025 |
| PGNYProgyny, Inc. |
1,3 mld USD |
4,5% |
2025 |
| PLDPrologis, Inc. |
8,8 mld USD |
37,9% |
2025 |
| PRLGPrologium Holding Inc. |
b.d. |
b.d. |
b.d. |
| PPCBPropanc Biopharma, Inc. |
b.d. |
b.d. |
2026 |
| PTIXProtagenic Therapeutics, Inc. |
0 USD |
b.d. |
2026 |
| PTGXProtagonist Therapeutics, Inc |
46 mln USD |
-282,8% |
2025 |
| PLXProtalix BioTherapeutics, Inc. |
52,7 mln USD |
-12,5% |
2025 |
| TARAProtara Therapeutics, Inc. |
b.d. |
b.d. |
2025 |
| PSKRFProtector Forsikring |
b.d. |
b.d. |
b.d. |
| PRLBProto Labs Inc |
533,1 mln USD |
4,0% |
2025 |
| PKTXProtoKinetix, Inc. |
b.d. |
b.d. |
2025 |
| PRYMFPrysmian S.p.A. |
b.d. |
b.d. |
b.d. |
| PUBMPubMatic, Inc. |
282,9 mln USD |
-5,1% |
2025 |
| PPHCPublic Policy Holding Company, Inc. |
186,5 mln USD |
-20,9% |
2025 |
| PSAPublic Storage |
4,8 mld USD |
37,0% |
2025 |
| PULMPulmatrix, Inc. |
b.d. |
b.d. |
2025 |
| LUNGPulmonx Corp |
90,5 mln USD |
-59,7% |
2025 |
| PLSMPulsenmore Ltd. |
12,5 mln USD |
-39,6% |
2025 |
| PCTPureCycle Technologies, Inc. |
8,4 mln USD |
-2185,1% |
2025 |
| PRTCYPureTech Health plc |
4,8 mln USD |
1108,3% |
2024 |